New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern
Go back to New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern| Steel Excel, Inc. (NASDAQ: ADPT) | Delayed: 2.61 +0.01 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.60 | 52 Week High | $73.44 | |||
| Open | $2.54 | 52 Week Low | $7.91 | |||
| Day High | $2.64 | P/E | N/A | |||
| Day Low | $2.48 | EPS | $0.00 | |||
| Volume | 1,839,185 | |||||
